Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-01-20

Clinical Trial Update: the Safety, Tolerability and Pharmacokinetics of Mulberry Twig Alkaloids in Human [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluated the safety, tolerability, and pharmacokinetics of mulberry twig alkaloids in humans, including participants with overweight or obesity…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mulberry Twig Alkaloids

Snippet

Sponsor: Beijing Wehand-Bio Pharmaceutical Co., Ltd | Conditions: Overweight and Obesity, Healthy | Phase 1 | Status: COMPLETED